Doi.org/10.1001/jamainternmed.2016.3771
Revision as of 21:10, 30 July 2022 by 179.215.124.0 (talk) (Created page with "== Target Article == Notice of Retraction: Risedronate Sodium Therapy for Prevention of Hip Fracture in Men 65 Years or Older After Stroke. Arch Intern Med. 2005;165(15):1743-1748.; Sato Y, et al. ; NULL; 2016-9-1; https://doi.org/10.1001/jamainternmed.2016.3771 == Reasons == Note: Reasons not yet here included, but you are welcome to insert this information whenever you wish.")
Target Article[edit | edit source]
Notice of Retraction: Risedronate Sodium Therapy for Prevention of Hip Fracture in Men 65 Years or Older After Stroke. Arch Intern Med. 2005;165(15):1743-1748.; Sato Y, et al. ; NULL; 2016-9-1; https://doi.org/10.1001/jamainternmed.2016.3771
Reasons[edit | edit source]
Note: Reasons not yet here included, but you are welcome to insert this information whenever you wish.